Eisai
4523.T
#2011
Rank
NZ$13.78 B
Marketcap
$48.91
Share price
-0.53%
Change (1 day)
-36.38%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Cash on Hand

Cash on Hand as of March 2024 : NZ$3.56 Billion

According to Eisai's latest financial reports the company has NZ$3.56 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Eisai - Cash on Hand chart (from 2009 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-03-31NZ$3.20 B-12.01%
2022-03-31NZ$3.64 B12.92%
2021-03-31NZ$3.22 B-18.06%
2020-03-31NZ$3.93 B1.18%
2019-03-31NZ$3.89 B3.64%
2018-03-31NZ$3.75 B28.07%
2017-03-31NZ$2.93 B15.88%
2016-03-31NZ$2.53 B12.96%
2015-03-31NZ$2.24 B14.82%
2014-03-31NZ$1.95 B-17.81%
2013-03-31NZ$2.37 B-14.15%
2012-03-31NZ$2.76 B-3.5%
2011-03-31NZ$2.86 B23.52%
2010-03-31NZ$2.32 B-15.39%
2009-03-31NZ$2.74 B72.15%
2008-03-31NZ$1.59 B-25.43%
2007-03-31NZ$2.13 B-20.45%
2006-03-31NZ$2.68 B39.44%
2005-03-31NZ$1.92 B-13.6%
2004-03-31NZ$2.22 B6.64%
2003-03-31NZ$2.09 B-6.6%
2002-03-31NZ$2.23 B-11.05%
2001-03-31NZ$2.51 B-13.63%
2000-03-31NZ$2.91 B